Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-29

FDA Approved: EPINEPHRINE — Original Application (BPI Labs, LLC)

View source ↗

Summary

The FDA approved an original NDA for a new Epinephrine product from BPI Labs, LLC, for emergency treatment of anaphylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPINEPHRINE (EPINEPHRINE)

Snippet

ORIG AP for EPINEPHRINE (EPINEPHRINE)